Literature DB >> 23520035

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

Tor Olofsson1, Ingemar F Petersson, Jonas K Eriksson, Martin Englund, Julia F Simard, Jan-Åke Nilsson, Pierre Geborek, Lennart T H Jacobsson, Johan Askling, Martin Neovius.   

Abstract

OBJECTIVE: To identify predictors of sick leave and disability pension in patients with early rheumatoid arthritis (RA).
METHODS: Individuals aged 19-59 years diagnosed with early RA (≤12 months symptom duration) were identified in the Swedish Rheumatology Quality Register (1999-2007; n=3029). We retrieved days of sick leave and disability pension from the Swedish Social Insurance Agency and baseline predictors of total work days lost during 3 years after RA diagnosis were investigated using linear regression. Due to effect modification by baseline work ability (defined as work days lost the month before diagnosis), analyses were stratified into three categories: full=0 work days lost the month before diagnosis; partial=1-29 work days lost; and none=30 work days lost.
RESULTS: 71% of patients with full baseline work ability still had full work ability after 3 years compared with 36% (p<0.001) and 18% (p<0.001) of those with partial and no work ability at baseline, respectively. Elevated baseline levels of HAQ and DAS28, higher age, lower education level and unemployment were associated with more work days lost during 3 years in all strata of baseline work ability (all p<0.05). In a separate analysis, more objective variables (ESR, CRP and swollen joints) were not. Generally, the largest regression coefficients were seen for patients with partial baseline work ability.
CONCLUSIONS: Work ability at RA diagnosis was the most important predictor of 3-year sick leave and disability pension. Taking this into account, HAQ, DAS28, age and education level were also significant predictors, whereas ESR and CRP were not.

Entities:  

Keywords:  Disease Activity; Early Rheumatoid Arthritis; Epidemiology; Outcomes research

Mesh:

Year:  2013        PMID: 23520035     DOI: 10.1136/annrheumdis-2012-202911

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis.

Authors:  Maarten M Steinz; Malin Persson; Bejan Aresh; Karl Olsson; Arthur J Cheng; Emma Ahlstrand; Mats Lilja; Tommy R Lundberg; Eric Rullman; Kristina Ängeby Möller; Katalin Sandor; Sofia Ajeganova; Takashi Yamada; Nicole Beard; Björn Cg Karlsson; Pasi Tavi; Ellinor Kenne; Camilla I Svensson; Dilson E Rassier; Roger Karlsson; Ran Friedman; Thomas Gustafsson; Johanna T Lanner
Journal:  JCI Insight       Date:  2019-03-28

2.  The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study.

Authors:  Elena Myasoedova; John M Davis; Vanessa L Kronzer; Rachel E Giblon; Elizabeth J Atkinson; Nathan K LeBrasseur; Cynthia S Crowson
Journal:  Semin Arthritis Rheum       Date:  2021-12-31       Impact factor: 5.431

3.  The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study.

Authors:  Oonagh Wilson; John Kirwan; Emma Dures; Enid Quest; Sarah Hewlett
Journal:  J Foot Ankle Res       Date:  2017-01-25       Impact factor: 2.303

4.  Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.

Authors:  Lauren F Collins; Meredith E Clement; Jason E Stout
Journal:  Open Forum Infect Dis       Date:  2017-06-06       Impact factor: 3.835

5.  Impact of improved recording of work-relatedness in primary care visits at occupational health services on sickness absences: study protocol for a randomised controlled trial.

Authors:  Salla Atkins; Ulla Ojajärvi; Nina Talola; Mervi Viljamaa; Jaakko Nevalainen; Jukka Uitti
Journal:  Trials       Date:  2017-07-26       Impact factor: 2.279

6.  Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis.

Authors:  Juan Ji; Lijuan Zhang; Qiuxiang Zhang; Rulan Yin; Ting Fu; Liren Li; Zhifeng Gu
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

7.  Prevalence, impact and care of foot problems in people with rheumatoid arthritis: results from a United Kingdom based cross-sectional survey.

Authors:  Oonagh Wilson; Sarah Hewlett; James Woodburn; Jon Pollock; John Kirwan
Journal:  J Foot Ankle Res       Date:  2017-10-27       Impact factor: 2.303

8.  Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study.

Authors:  Anna Eberhard; Stefan Bergman; Thomas Mandl; Tor Olofsson; Maria Rydholm; Lennart Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.156

9.  Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study.

Authors:  Wei Zhang; Nick Bansback; Huiying Sun; Ronald Pedersen; Sameer Kotak; Aslam H Anis
Journal:  RMD Open       Date:  2015-04-08

10.  Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy.

Authors:  Johanna Callhoff; Katinka Albrecht; Georg Schett; Angela Zink; Gisela Westhoff
Journal:  RMD Open       Date:  2015-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.